Shallcross Steven A
CIK 0001263501
CEO and CFODirector
Filings
11
Latest Jan 6, 2026
Issuers covered
2
Showing
11 of 11
Page 1
Track record
7 of 7 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 7 | 71% | +20.7% | +18.6% | +97.8% | -26.0% |
| 90 days | 7 | 14% | -13.1% | -20.3% | +47.8% | -33.7% |
| 180 days | 7 | 14% | -5.5% | -14.3% | +80.4% | -40.4% |
| 365 days | 7 | 0% | -45.1% | -50.0% | -6.5% | -61.4% |
Issuers
Companies where Shallcross Steven A has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| TOVX | Theriva Biologics, Inc. | 10 | Jan 6, 2026 |
| ELYS | Elys Game Technology, Corp. | 1 | Feb 16, 2023 |
All filings
11 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|